HER2DX Could Aid Chemotherapy Decision-Making in HER2+ Early-Stage Breast Cancer Read More » November 6, 2025
Adjuvant Durvalumab Plus Tremelimumab Yields DFS Advantage in Resected RCC Read More » November 6, 2025
Comprehensive Molecular Profiling of Renal Medullary Carcinoma Identifies TROP2 As a Promising Therapeutic Target Read More » November 6, 2025
Pancreatic cancer trials fuels hope for new drug fast-tracked by the FDA Read More » November 6, 2025
